Z
16.62
-0.72 (-4.15%)
| Penutupan Terdahulu | 17.34 |
| Buka | 16.66 |
| Jumlah Dagangan | 1,694,977 |
| Purata Dagangan (3B) | 796,315 |
| Modal Pasaran | 1,867,337,856 |
| Harga / Jualan (P/S) | 4.15 |
| Harga / Buku (P/B) | 2.90 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Keuntungan | -60.26% |
| Margin Operasi (TTM) | -52.88% |
| EPS Cair (TTM) | -2.50 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 22.20% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 23.72% |
| Nisbah Semasa (MRQ) | 3.26 |
| Aliran Tunai Operasi (OCF TTM) | -186.46 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -184.48 M |
| Pulangan Atas Aset (ROA TTM) | -15.50% |
| Pulangan Atas Ekuiti (ROE TTM) | -32.05% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Zai Lab Limited | Menurun | Menurun |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | -2.5 |
| Purata | -0.30 |
|
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 1.47% |
| % Dimiliki oleh Institusi | 52.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Rock Springs Capital Management Lp | 31 Mar 2026 | 814,707 |
| C Worldwide Group Holding A/S | 31 Mar 2026 | 510,000 |
| B Group, Inc. | 31 Mar 2026 | 450,646 |
| Nan Fung Trinity (Hk) Ltd | 31 Mar 2026 | 346,466 |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| DU YING | - | 18.57 | -107,700 | -2,008,147 |
| Jumlah Keseluruhan Kuantiti Bersih | -107,700 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,008,147 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 18.57 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| DU YING | Pegawai | 27 May 2026 | Dibuang (-) | 87,843 | 18.69 | 1,641,786 |
| DU YING | Pegawai | 26 May 2026 | Dibuang (-) | 19,857 | 18.45 | 366,362 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |